Peripheral neuropathies during the COVID-19 pandemic: is there a relation?

Authors:
Trentinaglia M; Lippi G; Salvagno GL; Rispoli MG; De Angelis MV and 15 more

Journal:
Immunol Res

Publication Year: 2022

DOI:
10.1007/s12026-022-09272-1

PMCID:
PMC8890815

PMID:
35237933

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Immunol Res

Abbreviation: Immunol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoinflammatory diseases and the kidney.
Hegazy MT; Fayed A; Nuzzolese R and 2 more (2023) - Transparency Score: 3/6
Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe?
Iervasi E; Strangio A; Greco L and 2 more (2023) - Transparency Score: 3/6
COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case rep…
Syrmou V; Liaskos C; Ntavari N and 6 more (2023) - Transparency Score: 3/6
COVID-19 vaccines adverse events: potential molecular mechanisms.
Lamprinou M; Sachinidis A; Stamoula E and 2 more (2023) - Transparency Score: 2/6
Efficacy and safety of IL-23 inhibitors in the treatment of psoriatic arthritis: a meta-analysis ba…
Huang X; Shentu H; He Y and 4 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestS. Ferrari received support for attending scientific meetings by Shire, Sanofi Genzyme and Euroimmun. S. Mariotto received support for attending scientific meetings by Merck and Euroimmun and received speaker honoraria from Biogen. The other authors report no competing interests. Ethics approval, consent to participate and consent for publicationThe study was approved by the local Bioethics Committee (Comitato Etico per la Sperimentazione Clinica, Azienda Ospedaliera Universitaria Integrata di Verona, BIOB-NEU-DNA-2014, protocol 13582). Conflict of interest S. Ferrari received support for attending scientific meetings by Shire, Sanofi Genzyme and Euroimmun. S. Mariotto received support for attending scientific meetings by Merck and Euroimmun and received speaker honoraria from Biogen. The other authors report no competing interests."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025